Pharmaceuticals News

FORT LEE, N.J., July 10, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...

Selskabsmeddelelse 10/2026                                                                   10. juli 2026                                                                         Indkaldelse til...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL PROGRAMS Paris, July 10, 2026, 6pm CET AB Science SA...

COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR SON PROGRAMME CLINIQUE AVEC L’ARRET DE CERTAINES ETUDES CLINIQUES NON PRIORITAIRES EN VUE DE SE CONCENTRER SUR DEUX PROGRAMMES CLINIQUES Paris, le...

Selskabsmeddelelse 9/2026                                                                  10. juli 2026                                                             Betinget køb af 3...

Cosmos Health launches subscription model.

Management to participate in investor meetings on July 14-15 in Boston Denver, CO, July 10, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a...

Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ® on-body injector (OBI) offers a...